AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ACST Quote Acasti Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 3 10 8
ShortTermInvest 7 0 0
Cash 10 10 8
AccountReceivab 0 0 1
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 11 10 9
PPE 0 3 4
AccumulatedDepr 0 0 -1
NetPPE 0 3 3
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 15 12 10
OtherLTAssets 2 0 1
TotalNonCurrent 17 15 13
TotalAssets 29 25 23
ShortTermDebt 0 0 0
AccountsPayable 0 0 3
TaxesPayable 0 0 0
AccruedLiabilit 0 1 2
DeferredRevenue 0 0 0
OtherCurrentLia 1 1 1
TotalCurrentLia 1 2 7
Debt 0 1 2
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 6
TotalNonCurrent 0 2 8
TotalLiabilitie 1 4 15
CommonStock 0 0 0
AdditionalPaidI 67 72 80
RetainedEarning -40 -51 -72
AccumulatedOthe 0 0 0
TotalStockholde 27 22 8
TotalLiabilitie 29 25 23
Acasti Pharma Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Acasti Pharma Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.